0000899243-23-013275.txt : 20230518
0000899243-23-013275.hdr.sgml : 20230518
20230518171857
ACCESSION NUMBER: 0000899243-23-013275
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230516
FILED AS OF DATE: 20230518
DATE AS OF CHANGE: 20230518
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KOZARICH JOHN W
CENTRAL INDEX KEY: 0001223000
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33093
FILM NUMBER: 23937169
MAIL ADDRESS:
STREET 1: 10275 SCIENCE CENTER DR
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LIGAND PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000886163
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770160744
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3911 SORRENTO VALLEY BLVD
STREET 2: SUITE 110
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-550-7500
MAIL ADDRESS:
STREET 1: 3911 SORRENTO VALLEY BLVD
STREET 2: SUITE 110
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-05-16
0
0000886163
LIGAND PHARMACEUTICALS INC
LGND
0001223000
KOZARICH JOHN W
3911 SORRENTO VALLEY BOULEVARD,
SUITE 110
SAN DIEGO
CA
92121
1
0
0
0
0
Common Stock
2023-05-16
4
S
0
4444
77.2009
D
38488
D
The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $77.20 to $77.24. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The number reflected in Column 5 reconciles the total number of shares beneficially held following the transactions reported herein.
/s/ Andrew Reardon, Attorney-in-Fact for John W. Kozarich
2023-05-18